• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATC药物分类的精准药代动力学/药物代谢特征

Refined ADME Profiles for ATC Drug Classes.

作者信息

Menestrina Luca, Parrondo-Pizarro Raquel, Gómez Ismael, Garcia-Serna Ricard, Boyer Scott, Mestres Jordi

机构信息

Chemotargets SL, Parc Cientific de Barcelona, Baldiri Reixac 4 (TR-03), 08028 Barcelona, Catalonia, Spain.

Institut de Quimica Computacional i Catalisi, Facultat de Ciencies, Universitat de Girona, Maria Aurelia Capmany 69, 17003 Girona, Catalonia, Spain.

出版信息

Pharmaceutics. 2025 Feb 28;17(3):308. doi: 10.3390/pharmaceutics17030308.

DOI:10.3390/pharmaceutics17030308
PMID:40142973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944659/
Abstract

Modern generative chemistry initiatives aim to produce potent and selective novel synthetically feasible molecules with suitable pharmacokinetic properties. General ranges of physicochemical properties relevant for the absorption, distribution, metabolism, and excretion (ADME) of drugs have been used for decades. However, the therapeutic indication, dosing route, and pharmacodynamic response of the individual drug discovery program may ultimately define a distinct desired property profile. A methodological pipeline to build and validate machine learning (ML) models on physicochemical and ADME properties of small molecules is introduced. The analysis of publicly available data on several ADME properties presented in this work reveals significant differences in the property value distributions across the various levels of the anatomical, therapeutic, and chemical (ATC) drug classification. For most properties, the predicted data distributions agree well with the corresponding distributions derived from experimental data across fourteen drug classes. The refined ADME profiles for ATC drug classes should be useful to guide the generation of advanced lead structures directed toward specific therapeutic indications.

摘要

现代生成化学计划旨在生产具有合适药代动力学特性的强效且选择性高的新型合成可行分子。与药物吸收、分布、代谢和排泄(ADME)相关的物理化学性质的一般范围已经使用了数十年。然而,单个药物发现计划的治疗适应症、给药途径和药效学反应最终可能决定一个独特的理想性质概况。本文介绍了一种用于构建和验证基于小分子物理化学性质和ADME性质的机器学习(ML)模型的方法流程。对本研究中呈现的几种ADME性质的公开可用数据的分析揭示了在解剖学、治疗学和化学(ATC)药物分类的各个层面上性质值分布的显著差异。对于大多数性质,预测数据分布与来自14个药物类别的实验数据得出的相应分布非常吻合。ATC药物类别的精细ADME概况应有助于指导针对特定治疗适应症的先进先导结构的生成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/074bbe13cfa4/pharmaceutics-17-00308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/495fd833312c/pharmaceutics-17-00308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/a84a8af07b17/pharmaceutics-17-00308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/2c3f0961526a/pharmaceutics-17-00308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/d6bc89f462a1/pharmaceutics-17-00308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/074bbe13cfa4/pharmaceutics-17-00308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/495fd833312c/pharmaceutics-17-00308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/a84a8af07b17/pharmaceutics-17-00308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/2c3f0961526a/pharmaceutics-17-00308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/d6bc89f462a1/pharmaceutics-17-00308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69e8/11944659/074bbe13cfa4/pharmaceutics-17-00308-g005.jpg

相似文献

1
Refined ADME Profiles for ATC Drug Classes.ATC药物分类的精准药代动力学/药物代谢特征
Pharmaceutics. 2025 Feb 28;17(3):308. doi: 10.3390/pharmaceutics17030308.
2
The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.从药物发现中ADME评价角度看计算机模拟模型的趋势与未来展望
Pharmaceutics. 2023 Nov 12;15(11):2619. doi: 10.3390/pharmaceutics15112619.
3
Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond.影响治疗性反义寡核苷酸ADME特性的因素:物理化学特性及其他
Curr Drug Metab. 2023;24(7):536-552. doi: 10.2174/1389200224666230418092626.
4
Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.用于预测药物吸收、分布、代谢和排泄(ADME)特性的局部和全局机器学习模型的系统评估。
Mol Pharm. 2023 Mar 6;20(3):1758-1767. doi: 10.1021/acs.molpharmaceut.2c00962. Epub 2023 Feb 6.
5
Perspective on a chemistry classification system for AI-assisted formulation development.人工智能辅助制剂研发的化学分类系统述评。
J Control Release. 2022 Dec;352:833-839. doi: 10.1016/j.jconrel.2022.10.040. Epub 2022 Nov 11.
6
Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.机器学习方法在计算机辅助药物设计中的应用进展。
Adv Drug Deliv Rev. 2015 Jun 23;86:83-100. doi: 10.1016/j.addr.2015.03.014. Epub 2015 May 30.
7
Artificial Intelligence in ADME Property Prediction.人工智能在 ADME 性质预测中的应用。
Methods Mol Biol. 2024;2714:307-327. doi: 10.1007/978-1-0716-3441-7_17.
8
Multitask Deep Learning Models of Combined Industrial Absorption, Distribution, Metabolism, and Excretion Datasets to Improve Generalization.结合工业吸收、分布、代谢和排泄数据集的多任务深度学习模型以提高泛化能力。
Mol Pharm. 2025 Apr 7;22(4):1892-1900. doi: 10.1021/acs.molpharmaceut.4c01086. Epub 2025 Mar 7.
9
ADME/tox comes of age: twenty years later.ADME/tox 崭露头角:二十年后。
Xenobiotica. 2024 Jul;54(7):352-358. doi: 10.1080/00498254.2023.2245049. Epub 2023 Aug 8.
10
Understanding predictions of drug profiles using explainable machine learning models.使用可解释的机器学习模型理解药物特性预测。
BioData Min. 2024 Aug 1;17(1):25. doi: 10.1186/s13040-024-00378-w.

本文引用的文献

1
Filling the Gap in and Evaluation for Saturated Fluorine-Containing Derivatives With Machine Learning.利用机器学习填补饱和含氟衍生物的[此处原文缺失相关内容]及评估方面的空白。
J Comput Chem. 2025 Jan 15;46(2):e70002. doi: 10.1002/jcc.70002.
2
MolE: a foundation model for molecular graphs using disentangled attention.MolE:一种基于解缠注意力的分子图基础模型。
Nat Commun. 2024 Nov 12;15(1):9431. doi: 10.1038/s41467-024-53751-y.
3
Perspectives on the use of machine learning for ADME prediction at AstraZeneca.在阿斯利康(AstraZeneca),关于使用机器学习进行 ADME 预测的观点。
Xenobiotica. 2024 Jul;54(7):368-378. doi: 10.1080/00498254.2024.2352598. Epub 2024 Aug 21.
4
Machine learning in preclinical drug discovery.机器学习在临床前药物发现中的应用。
Nat Chem Biol. 2024 Aug;20(8):960-973. doi: 10.1038/s41589-024-01679-1. Epub 2024 Jul 19.
5
Multi-Task ADME/PK prediction at industrial scale: leveraging large and diverse experimental datasets.工业规模的多任务 ADME/PK 预测:利用大型和多样化的实验数据集。
Mol Inform. 2024 Oct;43(10):e202400079. doi: 10.1002/minf.202400079. Epub 2024 Jul 8.
6
ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries.ADMET-AI:用于评估大规模化学文库的机器学习 ADMET 平台。
Bioinformatics. 2024 Jul 1;40(7). doi: 10.1093/bioinformatics/btae416.
7
Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure.基于化学结构预测小分子药物药代动力学特征的机器学习框架。
Clin Transl Sci. 2024 May;17(5):e13824. doi: 10.1111/cts.13824.
8
Unleashing the power of generative AI in drug discovery.释放生成式人工智能在药物研发中的力量。
Drug Discov Today. 2024 Jun;29(6):103992. doi: 10.1016/j.drudis.2024.103992. Epub 2024 Apr 23.
9
admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties.admetSAR3.0:一个全面的用于探索、预测和优化化学 ADMET 性质的平台。
Nucleic Acids Res. 2024 Jul 5;52(W1):W432-W438. doi: 10.1093/nar/gkae298.
10
Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction.深度药代动力学:小分子药代动力学和毒性预测的深度学习。
Nucleic Acids Res. 2024 Jul 5;52(W1):W469-W475. doi: 10.1093/nar/gkae254.